Health Care Burden in Patients With Adrenal Insufficiency

Candace Gunnarsson1, Michael P Ryan1, Claudio Marelli2

  • 1CTI Clinical Trial and Consulting Services Inc., Covington, Kentucky 41011.

Insights

Patients with adrenal insufficiency (AI) face a significant healthcare cost burden, with higher expenditures and hospitalizations compared to controls. Adherence to glucocorticoid therapy can reduce these costs.

Area of Science:

  • Endocrinology
  • Health Economics
  • Real-World Evidence

Background:

  • Adrenal insufficiency (AI) encompasses primary (PAI), pituitary (PIT), and congenital adrenal hyperplasia (CAH) forms.
  • Understanding the economic impact of AI is crucial for healthcare resource allocation.

Purpose of the Study:

  • To estimate the annual healthcare burden associated with AI using real-world data.
  • To compare healthcare expenditures across different AI subtypes and treatment regimens.

Main Methods:

  • Utilized a US payer database (>108 million members) to identify 10,383 AI patients.
  • Matched AI patients 1:1 with controls based on demographics and insurance.
  • Employed multivariable expenditure models, analyzing subsets by glucocorticoid therapy and adherence.

Main Results:

  • AI patients incurred significantly higher annual healthcare costs (PAI: $18,624, PIT: $32,218, CAH: $7677) vs. controls.
  • AI patients experienced 8-10 times more inpatient hospital days annually.
  • Multiple steroid therapies increased expenditures; higher adherence to hydrocortisone correlated with lower costs in PAI and PIT.

Conclusions:

  • AI imposes a substantial annual healthcare burden, varying by cause and treatment.
  • Optimizing glucocorticoid replacement adherence can mitigate healthcare expenditures in AI patients.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.4K
Anatomy of the Adrenal Glands01:17

Anatomy of the Adrenal Glands

The adrenal or supra-renal glands, situated above the kidneys and aligned with the twelfth rib, are paired pyramid-shaped structures crucial for the body's stress response. During stress, these glands secrete hormones vital for adaptive physiological reactions.
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
5.0K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
5.6K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
355
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
403
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
857